Meitav Investment House’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Buy
+27,178
New +$1.38M 0.01% 217
2024
Q1
Sell
-3,068,436
Closed -$166M 281
2023
Q4
$166M Buy
3,068,436
+436,752
+17% +$21.3M 2.43% 11
2023
Q3
$130M Buy
2,631,684
+380,057
+17% +$20.2M 2.11% 10
2023
Q2
$126M Buy
2,251,627
+20,752
+0.9% +$1.14M 2.02% 10
2023
Q1
$121M Buy
2,230,875
+781,235
+54% +$41.6M 2.09% 6
2022
Q4
$76.8M Buy
1,449,640
+391,545
+37% +$19.9M 1.32% 15
2022
Q3
$50.6M Sell
1,058,095
-41,177
-4% -$2.14M 0.89% 33
2022
Q2
$55.2M Buy
1,099,272
+124,333
+13% +$6.78M 0.94% 27
2022
Q1
$59.3M Sell
974,939
-677,966
-41% -$40.4M 0.88% 34
2021
Q4
$109M Buy
1,652,905
+295,135
+22% +$18.9M 1.77% 11
2021
Q3
$85.2M Buy
1,357,770
+525,672
+63% +$33.5M 1.4% 14
2021
Q2
$50.1M Buy
832,098
+656,634
+374% +$38M 1.28% 22
2021
Q1
$9.66M Buy
175,464
+89,934
+105% +$4.99M 0.27% 85
2020
Q4
$4.67M Sell
85,530
-577,818
-87% -$30.2M 0.18% 95
2020
Q3
$33.1M Buy
663,348
+131,016
+25% +$6.34M 1.64% 15
2020
Q2
$23.5M Buy
532,332
+50,604
+11% +$2.16M 1.4% 18
2020
Q1
$18.1M Buy
+481,728
New +$20.3M 1.35% 23
2019
Q2
Sell
-6,840
Closed -$262K 458
2019
Q1
$262K Buy
+6,840
New +$248K 0.01% 334
2018
Q4
Sell
-6,870
Closed -$260K 397
2018
Q3
$260K Hold
6,870
0.01% 405
2018
Q2
$491K Buy
+6,870
New +$224K 0.02% 325

Other funds holding IHI

Meitav Investment House's IHI Position: Q2 2026 in Review

Meitav Investment House opened a new position in iShares US Medical Devices ETF (IHI) in Q2 2026: 27,178 shares worth $1.34M. The stake represents 0.01% of the portfolio and ranks #217 among its holdings. This is a return to the name: Meitav Investment House previously reported a position in IHI as recently as Q4 2023.

Meitav Investment House first reported a position in IHI in Q2 2018 and has held it in 20 quarters since. The position peaked at $166M in Q4 2023. 502 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Meitav Investment House held 27,178 shares of iShares US Medical Devices ETF worth $1.34M as of Q2 2026.
  • iShares US Medical Devices ETF was a new Meitav Investment House position in Q2 2026.
  • iShares US Medical Devices ETF made up 0.01% of Meitav Investment House's portfolio in Q2 2026, its #217 holding.
  • Meitav Investment House first reported a position in iShares US Medical Devices ETF in Q2 2018 and has held it in 20 quarters since.
  • Meitav Investment House's iShares US Medical Devices ETF position peaked at $166M in Q4 2023.
  • 502 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Meitav Investment House's 13F filing for Q2 2026, filed 20 Jul 2026.